key: cord-1035135-7ejyw9hl
authors: Franciscus Xaverius Moonen, Hanneke Pierre; Louise van Zanten, Florianne Johanna; Driessen, Luuk; de Smet, Vivienne; Slingerland-Boot, Rianne; Mensink, Marco; Hubert van Zanten, Arthur Raymond
title: Association of Bioelectric Impedance Analysis Body Composition and disease severity in COVID-19 hospital ward and ICU patients: the BIAC-19 study
date: 2020-10-21
journal: Clin Nutr
DOI: 10.1016/j.clnu.2020.10.023
sha: 2ef9ac77f68e2440ab20066462fc27b63a2a5f62
doc_id: 1035135
cord_uid: 7ejyw9hl

Background The current severe acute respiratory syndrome coronavirus 2 pandemic is unprecedented in its impact. It is essential to shed light on patient characteristics that predispose to a more severe disease course. Obesity, defined as a BMI>30kg/m2, is suggested to be one of these characteristics. However, BMI does not differentiate between fat mass and lean body mass, or the distribution of fat tissue. The aim of the present study was to assess the body composition of COVID-19 patients admitted to the ward or the ICU and identify any associations with severity of disease. Methods We performed an observational cross-sectional cohort study. Bioelectric impedance analysis was conducted amongst all confirmed COVID-19 patients admitted to the ward or ICU of our hospital in the Netherlands, between April 10 and 17, 2020. Body water measurements and derived values were recalculated to dry weight, using a standard ratio of extracellular water to total body water of 0.38. Data were compared between the ward and ICU patients, and regression models were used to assess the associations between baseline characteristics, body composition, and several indicators of disease severity, including a composite score of mortality, morbidity, and ICU admission. Results Fifty-four patients were included, of which 30 in the ward and 24 in the ICU. The mean age was 67 years (95%-CI 64 - 71), and 34 (63%) were male. Mean BMI was 29.7 (95%-CI 28.2 - 31.1) kg/m2 and did not differ between groups. Body composition values were not independently associated with disease severity. In multiple logistic regression analyses, a low phase angle was associated with COVID-19 severity in the composite score (OR 0.299, p=.046). Conclusion We found no significant associations between body composition, including fat mass, visceral fat area, and fat-free mass, and disease severity in our population of generally overweight COVID-19 patients. A lower phase angle did increase the odds of severe COVID-19. We believe that factors other than body composition play a more critical role in the development of severe COVID-19.

Severe acute respiratory syndrome coronavirus-2, SARS-CoV-2, has rapidly spread across countries and continents since its first appearance in late 2019, causing high incidences of Corona Virus Disease-2019 . Rates of intensive care (ICU) admission are 10.9% among hospitalized COVID-19 patients 1 . ICU patients with severe COVID-19 typically receive prolonged invasive mechanical ventilation with a reported median of 18 days and a case-fatality rate up to 49% 2, 3 .

Studies describing characteristics of COVID-19 patients requiring hospitalization or ICU admission show these factors correlate with advanced age, male sex, high body mass index (BMI), and several obesity-related comorbidities [4] [5] [6] [7] . Among COVID-19 ICU patients, obesity is frequently encountered.

Increased disease severity with increasing BMI has been shown 8 . High BMI is a risk factor for hospitalization in persons <60 years of age, a group otherwise less severely affected 9 . Parallels can be drawn with other viral infections, such as H1N1 influenza, that disproportionally impact obese individuals 6, 10, 11 . A hypothesis is that obese individuals have decreased respiratory volumes and lung compliance due to abdominal obesity 6, 10, 11 . However, adipose tissue may also serve as a reservoir for SARS-CoV-2, predisposing obese individuals to a higher or more persistent viral load [12] [13] [14] [15] . As men are more often and more severely affected by COVID-19 compared with women, despite a lower incidence of obesity, it could be hypothesized that not merely fat percentage, but the location of fat tissue is essential, as men are more prone to visceral fat accumulation 16 . A possible parallel is found in hepatitis C, where visceral obesity is associated with a higher viral load 17 .

Addressing which factors influence susceptibility to a severe course of COVID-19 is essential to aid in prevention, earlier treatment, and organization of health care. As such, BMI as a distinguishing factor is inadequate, as it does not differentiate between different tissues, nor the fat tissue distribution.

Several studies have demonstrated that high BMI was associated with lower mortality in critically ill, pneumonia, and Acute Respiratory Distress Syndrome (ARDS) patients [18] [19] [20] [21] . These findings could be explained by the lack of discriminatory power of BMI to differentiate between body fat and lean mass and the higher absolute amount of lean mass in non-sarcopenic obesity, compared with individuals J o u r n a l P r e -p r o o f with an ideal-weight BMI 22 . Indeed, in critically ill patients, it has been shown that BMI is not an independent predictor of mortality when corrected for muscle area 23 .

Bioelectrical impedance analysis (BIA) is a validated, non-invasive method for assessing body composition. It measures the opposition to an alternating current passing through body compartments (resistance) and the delay in conduction by membranes (reactance). BIA uses these measurements to estimate the contribution of various tissues to the (segmental) body weight accurately and provides markers for cellular integrity (phase angle). BIA is not yet widely implemented in the ICU, partly because the interpretation of some results is complicated in case of altered hydration status, as is common amongst the critically ill 24 . However, methods to calculate dry body weight values have been described for dialysis patients, where fluid overload is prevalent 25, 26 . The ratio between extracellular and total body water, as an indicator of hydration status, is easy to use, intuitive and validated as a predictor of survival in these patients 27, 28 . This provides a theoretical justification to apply this technique to ICU patients.

In this study, we aimed to measure BIA body composition amongst COVID-19 patients in the ward and the ICU to uncover associations between body composition and the course of the disease.

This cross-sectional observational cohort study was performed at Gelderse Vallei Hospital, a The InBody S10 uses segmental impedance and reactance at multiple frequencies to determine total body water (TBW), (segmental) extracellular water (ECW), and the individual ECW/TBW-ratio ( Figure   1 ). High-frequency currents pass through the TBW, whereas low-frequency currents cannot penetrate To correct for iatrogenic over-or dehydration of the extracellular compartment, leading to over-or underestimation of derived values, estimated values derived from ECW were recalculated to dry, or euhydrated weight, using a standardized ECW/TBW of 0.38 (reference value for healthy persons).

Demographic, radiological and clinical data were collected from local electronic medical record systems MetaVision® (iMDsoft, Tel Aviv, Israel) and NeoZIS® (MI Consultancy, Katwijk, The Netherlands). The recorded data included: age, sex, co-morbidities, clinical scores, laboratory results, radiological scores, limited treatment plans (LTP), and body temperature. Cumulative fluid balance (CFB) on the BIA measurement day was recorded whenever available in ICU patients. CFB is not recorded routinely in ward patients in our hospital.

The 28-day outcomes, including ICU-and hospital free days, complications, organ support free days (e.g., ventilation-free days and vasopressor-free days), and mortality were recorded. Expected complications were thrombo-embolic events, renal failure and delirium. Other complications were considered when occurring twice or more in the study population. Furthermore, total ICU and hospital length of stay (ICU LOS resp. HLOS), and hospital discharge destination were recorded.

Disease severity was defined in multiple ways. First, ICU admission for severe COVID-19 was considered. Additional parameters were 28-day mortality and complications. A composite score of ICU-admission and complications, including mortality, was created. A score of 1 indicated that at least one of the criteria was met, while a score of 0 was assigned to those patients without ICU admission and complications. For the ICU patient group, ventilation-free days and vasopressor-free days, were considered continuous outcome measures related to disease severity. 

Between April 10 and April 17, 2020, 55 patients were eligible for inclusion ( Figure 2 ). One patient declined participation; none were excluded. Four (ward) patients (7%) were confirmed by strong clinical suspicion and CORADS ≥3 despite negative initial RT-PCR (not repeated), all others had a positive initial RT-PCR. Two patients were briefly (<24h) admitted to the ICU and did not receive any specialized care before discharge; therefore, they were analyzed in the ward-group. In total, 54 

The 28-day outcome measures are summarized in Table 3 Table 4 summarizes the odds ratios derived from the multiple regression analysis, with age, sex, SOFA score at admission and days between hospital admission and measurement used as covariates.

None of the BIA values, including fat mass, VFA, and FFM, was significantly associated with being admitted to the ICU. More fluid overload, higher ECW/TBW-ratio, and decreased PA were associated with increased risk for mortality. The composite outcome score yielded a significant inverse association with PA (OR 0.299, p=.046).

We measured body composition by BIA in COVID-19 patients admitted to general wards and the ICU.

Although the average patient was overweight, we did not find differences in BMI, nor significant associations between fat mass, fat distribution (visceral fat localization), or fat-free mass (representing the lean body mass) and the severity of disease.. However, a lower phase angle at 50 kHz was associated with an increase in disease severity, reflected by the need for ICU admission, morbidity and mortality.

Multiple studies have shown an association between increased BMI and hospital and ICU admission, mechanical ventilation, and mortality in COVID-19 patients 2, 8, [34] [35] [36] . Obesity-related co-morbidities are prevalent amongst individuals infected by COVID-19 5, 7 . 37 . However, BMI does not incorporate the quantity and distribution of different tissues and is a crude estimation of body composition. Previously, this has led to misinterpretations due to ethnic variability in body ratios, proportion of subcutaneous versus visceral fat, and contribution of muscle mass to body weight 38 .The latter is likely the explanation behind the obesity-mortality-paradox, as it suggested obesity is protective and associated with greater survival 22, 23 . By measuring BIA body composition, we used a more precise method to study associations between increased body fat mass and visceral fat area and disease severity in COVID-19 patients.

Remarkably, we did not find differences in body composition between COVID-19 ward and ICU Expectedly, we found that the SOFA-score, an indicator of disease severity, was strongly associated with ICU-admission. Additionally, plasma CK at hospital admission was significantly increased in the eventual ICU-group. This was also observed in a cohort of COVID-19 patients in Wuhan, China 40 .

Other possible biomarkers upon hospital admission such as ferritin, CRP, and D-dimer were notsignificantly more elevated in ICU patients, although the number of observations were low. No other baseline characteristics were associated with ICU-admission.

Our data demonstrate the potential of PA as a predictor for disease severity in COVID-19 patients. PA has been repeatedly proven to predict morbidity and mortality in other patient groups [41] [42] [43] . We found no correlations between body composition values and disease severity. A single-center, retrospective study assessing the association between computer tomography-based measurements of visceral fat area and COVID-19 severity found a positive correlation 44 . However, this study was conducted among 30 patients, of whom only 13 were admitted to the ICU. Disease severity was defined as need for ICU admission and invasive mechanical ventilation, and morbidity and mortality were not considered.

Thus, both the power and comparability to our study are limited.

We encountered no issues in performing BIA measurements during this study. Nevertheless, we recognize that logistical (time, training) or physical barriers (pulse oximeters, bandages) can potentially complicate (routine) BIA measurements, especially in a busy ICU environment. Other bedside techniques to evaluate muscle mass and quality are available, but come with their own J o u r n a l P r e -p r o o f limitations. Muscle ultrasound can be useful to measure muscle quality, quantity and the pennation angle, but performing ultrasound reliably requires training and practice and is potentially susceptible to intra-and inter-observer variability 43, 44 . BIA is quick and requires only basic training, adding to the feasibility of use of the technique in the ICU. However, interpretation of the results must be done with caution as discussed below.

Under challenging conditions, we were able to assess body composition in COVID-19 patients.

However, there are several limitations. Firstly, the sample size of 54 can be considered small. Inhospital mortality was low (n=8,14.8%). Therefore, this cohort may yield insufficient power. A composite score was created to decrease the chance of type 1 error and to obtain a more encompassing definition of the disease course. Despite a robust retrospective basis for the visceral fat distribution hypothesis, we could not find associations between fat mass or distribution and disease severity. If our results prove reproducible, this could influence the direction of research for obesity and COVID-19.

Secondly,13(43%) of our ward patients had LTP, waiving ICU admission regardless of disease severity. However, sensitivity testing, yielded no different results. Therefore, we consider that potential selection bias for ICU admission based on perceived health or projected survival chances did not strongly influence our main findings.

Additionally, the most recently measured weight was used as input for the Inbody S10. Daily weight measurements were not always feasible in the ward patients during the pandemic. However, in this study population, the weight measurement was taken less than 48 hours prior to the BIA measurement. We therefore do not suspect this to be of significant influence on the results of this study.

Lastly, the cross-sectional nature of the BIA measurements complicates inter-individual comparability.

As both disease and treatment influence body composition, mainly through loss of LBM and increase J o u r n a l P r e -p r o o f of fluid overload, differences in time-to-measurement are an important consideration [45] [46] . In particular, for ICU patients, in whom fluid overload is common and has prevented BIA measurements from becoming a standard of practice. However, we circumvented this problem by using a multi-frequency BIA device (InBody S10), to enable differentiation between various fluid compartments 28, 47, 48 , adjustment for the time from hospital admission to measurement, and recalculation of body composition to dry weight to reduce the effect of overestimating LBM by fluid overload. We recognize that under ideal circumstances, serial BIA measurements provide more details on the course of loss of muscle mass and fluid overload in critically ill patients.

The method to recalculate BIA parameters to dry weight is based on the assumption that absolute fluid overload is defined as the difference between the measured ECW and the expected ECW under physiological conditions, in which ECW/TBW is estimated to be 0.38 25, 26, 28, [49] [50] [51] . This method has not been validated in ICU patients; however, it is incorporated in the 'dialysis mode' of the device, a validated method to determine dry weight in dialysis patients. This adjustment method is based on the assumption that fluid overload is exclusively located in the extracellular compartment and questions have been raised as to whether this is an oversimplification in prolonged or severe edema 52 . Likely, there is some muscle cell swelling (ICW) in severe edematous states, leading to overestimation of muscle mass 25, 52 . This may explain trends towards higher FFM, SLM, and SMI in the ICU group.

Nevertheless, no substantial impact of cell swelling on fat mass and visceral fat area can be expected. Therefore, we are confident that main findings persist. Moreover, additional calculations to estimate fluid overload are useful, as various studies have shown correlations between BIA derived fluid overload and outcome of disease 47, 53, 54 . The PA is calculated directly from reactance and resistance and is therefore less directly influenced by fluid overload, although theoretically, rapid fluid shifts can contribute to cell damage and, therefore, decrease PA 22 . In practice, PA indeed seems to vary with hydration. However, it remains a good indicator of clinical outcome, as fluid overload itself also negatively impacts outcome of disease, as was suggested by our findings 41, 42, 55 .

We assessed body composition using BIA in COVID-19 patients and compared ward and ICU patients. Our cohort was overweight, although this was not related to disease severity. Interestingly, 

Barthel index 20 [19 -20] 20 [18 -20] 20 [20 -20] In-hospital death f 6 (11%) 4 (13%) 2 (8%) 0.682 

Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

COVID 19 and the Patient with Obesity -The Editors Speak Out

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Obesity and its Implications for COVID-19 Mortality

Two Things about COVID-19 Might Need Attention

Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains

Obesity Increases the Duration of Influenza A Virus Shedding in Adults

Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms

Global gender disparities in obesity: a review

Association of visceral obesity with high viral load and histological findings in elderly patients with genotype 1 chronic hepatitis C

Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit

Obesity survival paradox in pneumonia: a meta-analysis

Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis

Obesity in the critically ill: a narrative review

Fat-free mass at admission predicts 28-day mortality in intensive care unit patients: the international prospective observational study Phase Angle Project

Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients

Measuring and monitoring lean body mass in critical illness

Changes in bioimpedance analysis components before and after hemodialysis

Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients

Monitoring of muscle mass in critically ill patients: comparison of ultrasound and two bioelectrical impedance analysis devices

Clinical usefulness of bioimpedance analysis for assessing volume status in patients receiving maintenance dialysis

Ontwikkelingen COVID-19 in grafieken

Epidemiologische situatie COVID-19 in Nederland

Reference values for skeletal muscle mass and fat mass measured by bioelectrical impedance in 390Â 565 UK adults

Reference values for the phase angle of the electrical bioimpedance: Systematic review and meta-analysis involving more than 250,000 subjects

Lengte en gewicht van personen, ondergewicht en overgewicht

Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia

Association of Obesity with Disease Severity among Patients with COVID-19

World Health Organization. Obesity and overweight

Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Use of bioelectrical impedance analysis for the assessment of nutritional status in critically ill patients

Bioelectrical impedance analysis-derived phase angle at admission as a predictor of 90-day mortality in intensive care patients

Assessment of Muscle Wasting in Long-Stay ICU Patients Using a

Clinical review: peripheral muscular ultrasound in the ICU

Bioelectrical phase angle and impedance vector analysis--clinical relevance and applicability of impedance parameters

Obesity and COVID-19: The role of visceral adipose tissue

Acute skeletal muscle wasting in critical illness

The impact of hydration status on the assessment of lean body mass by body electrical impedance in dialysis patients

Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording

Bioelectrical impedance analysis-part II: utilization in clinical practice

Association between ratio of measured extracellular volume to expected body fluid volume and renal outcomes in patients with chronic kidney disease: a retrospective single-center cohort study

Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis

Body composition in healthy older persons: role of the ratio of extracellular/total body water

Comparative assessment of skeletal muscle mass using computerized tomography and bioelectrical impedance analysis in critically ill patients

Fluid management in the intensive care unit: bioelectrical impedance vector analysis as a tool to assess hydration status and optimal fluid balance in critically ill patients

Association of hyperhydration evaluated by bioelectrical impedance analysis and mortality in patients with different medical conditions: Systematic review and meta-analyses

Fluid balance and phase angle as assessed by bioelectrical impedance analysis in critically ill patients: a multicenter prospective cohort study